NCT06943755 2026-04-17
STELLAR-311
Exelixis
Phase 2/3 Recruiting
Clinical Trials
3 trialsNCT05749289 2026-04-06
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3 Recruiting
NCT07165886 2025-09-10
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2/3 Recruiting